TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Other Working Capital Changes (2023 - 2026)

TAO Synergies' (TAOX) quarterly Other Working Capital Changes came in at $1697.0 in Q2 2026, up 100.83% on a YoY basis from $845.0 in Q2 2025, and up 100.33% quarter-over-quarter from -$516429.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Other Working Capital Changes (2023 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Other Working Capital Changes for 4 consecutive years, with $1697.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Working Capital Changes rose 100.83% year-over-year to $1697.0; the trailing twelve-month figure through Jun 2026 stood at -$349327.0 (down 164.45% YoY), and the FY2025 full-year result was $379826.0, up 203.18% from the prior year.
  • Other Working Capital Changes climbed to $1697.0 in Q2 2026 per TAOX's latest filing, from -$516429.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $419520.0 in Q1 2025 and bottomed at -$516429.0 in Q1 2026.
  • Historically, Other Working Capital Changes has averaged -$84103.8 across 4 years, with a median of -$148015.0 in 2024.
  • The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 306.36% in 2024, then jumped 281.86% in 2025.
  • Over 4 years, Other Working Capital Changes stood at -$180432.0 in 2023, then grew by 18.75% to -$146597.0 in 2024, then surged by 281.86% to $266603.0 in 2025, then sank by 99.36% to $1697.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered $1697.0, -$516429.0, and $266603.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,697.00
Jun 30, 2026 1,697.00
Mar 31, 2026 -516,429.00
Mar 31, 2026 -516,429.00
Dec 31, 2025 266,603.00
Dec 31, 2025 266,603.00
Sep 30, 2025 -101,198.00
Sep 30, 2025 -101,198.00
Jun 30, 2025 -205,099.00
Jun 30, 2025 -205,099.00
Mar 31, 2025 419,520.00
Mar 31, 2025 419,520.00
Dec 31, 2024 -146,597.00
Dec 31, 2024 -146,597.00
Sep 30, 2024 -199,919.00
Sep 30, 2024 -199,919.00
Jun 30, 2024 -149,433.00
Jun 30, 2024 -149,433.00
Mar 31, 2024 127,821.00
Mar 31, 2024 127,821.00